Style | Citing Format |
---|---|
MLA | Mahernia S, et al.. "Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy." Molecular Diversity, vol. 22, no. 1, 2018, pp. 173-181. |
APA | Mahernia S, Hassanzadeh M, Sharifi N, Mehravi B, Paytam F, Adib M, Amanlou M (2018). Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy. Molecular Diversity, 22(1), 173-181. |
Chicago | Mahernia S, Hassanzadeh M, Sharifi N, Mehravi B, Paytam F, Adib M, Amanlou M. "Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy." Molecular Diversity 22, no. 1 (2018): 173-181. |
Harvard | Mahernia S et al. (2018) 'Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy', Molecular Diversity, 22(1), pp. 173-181. |
Vancouver | Mahernia S, Hassanzadeh M, Sharifi N, Mehravi B, Paytam F, Adib M, et al.. Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy. Molecular Diversity. 2018;22(1):173-181. |
BibTex | @article{ author = {Mahernia S and Hassanzadeh M and Sharifi N and Mehravi B and Paytam F and Adib M and Amanlou M}, title = {Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy}, journal = {Molecular Diversity}, volume = {22}, number = {1}, pages = {173-181}, year = {2018} } |
RIS | TY - JOUR AU - Mahernia S AU - Hassanzadeh M AU - Sharifi N AU - Mehravi B AU - Paytam F AU - Adib M AU - Amanlou M TI - Structure-Based Pharmacophore Design and Virtual Screening for Novel Potential Inhibitors of Epidermal Growth Factor Receptor As an Approach to Breast Cancer Chemotherapy JO - Molecular Diversity VL - 22 IS - 1 SP - 173 EP - 181 PY - 2018 ER - |